Replies to post #300836 on Avid Bioservices Inc (CDMO)

[keep_trying]

Sulaco, to stay on point, the cancer screening effectiveness identified for the small sample size for Bavi detection of cancer was 100%, was it not? The weak dynamic is the small number of patients in the trial that had bloodwork for post Phase 3 trial halt evaluation. Not a lot, but enough to turn heads at ASCO, it seems.

Best wishes and IMO.
KT